Adipose Tissue and Mesenchymal Stem Cells: State of the Art and Lipogems® Technology Development

Current Stem Cell Reports

Volumn 2, Issue 3, 2016, Pages 304-312

  Tremolada, Carlo ^a   Colombo, Valeria ^a   Ventura, Carlo ^b  

^a Imaging Department   (Italy)

^b Stem Wave Institute for Tissue Healing (SWITH)   (Italy)

Author keywords

Adipose tissue; Adipose tissue derived mesenchymal stem cell; Adult stem cells; Lipogems ; Mesenchymal stem cell; Regenerative medicine

Indexed keywords

ADIPOSE TISSUE; CELL MANIPULATION; CLINICAL EFFECTIVENESS; EXTRACELLULAR MATRIX; GOOD MANUFACTURING PRACTICE; HUMAN; INFLAMMATION; KNEE PAIN; MAXILLOFACIAL SURGERY; MESENCHYMAL STEM CELL; NEURAL STEM CELL; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; PUBLICATION; REGENERATIVE MEDICINE; REVIEW; SURGICAL WOUND; WOUND HEALING;

EID: 85015781813     PISSN: None     EISSN: 21987866     Source Type: Journal    
DOI: 10.1007/s40778-016-0053-5     Document Type: Review

References (81)

1. Wilson EB. The cell in development and inheritance. New York: Macmillan; 1898.
2. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007;213(2):341–7.
3. Ventura C, Cantoni S, Bianchi F, Lionetti V, Cavallini C, Scarlata I, et al. Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endotelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcite rat hearts. J Biol Chem. 2007;282(19):14243–52.
4. Cavallari G, Olivi E, Bianchi F, Neri F, Foroni L, Valente S, et al. Mesenchymal stem cells and islet cotransplantation in diabetic rats: improve islet graft revascularization and function by human adipose tissue-derived stem cells preconditioned with natural molecule. Cell Transplant. 2012;21(12):2771–81.
5. Canaider S, Maioli M, Facchin F, et al. Human Stem Cell exposure to developmental stage zebrafish extracts: a novel strategy for turning stemness and senescence patterning. CellR4. 2014;2(5):1226.
6. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005;332(2):370–9.
7. Fraser JK, Schreiber R, Strem B, Zhu M, Alonso Z, Wulur I, et al. Plasticity of human adipose stem cells towards endothelial cells and cardiomyocytes. Nat Clin Pract Cardiovasc Med. 2006;3(Suppl1):S33–7.
8. Sen A, Lea-Currie YR, Suijkowska D, Franklin DM, Wilkison WO, Halvorsen YD, et al. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem. 2001;205(1):312–9.
9. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279–95.
10. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211–28.
11. Erickson GR, Gimble JM, Franklin DM, Rice HE, Awad H, Guilak F. Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun. 2002;290(2):763–9.
12. Halvorsen YC, Wilkison WO, Gimble JM. Adipose-derived stromal cells—their utility and potential in bone formation. Int J Obes Relat Metab Disord. 2000;24(4):S41–4.
13. Halvorsen YD, Franklin D, Bond AL, Hitt DC, Auchter C, Boskey AL, et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng. 2001;7(6):729–41.
14. Huang JI, Beanes SR, Zhu M, Lorenz HP, Hedrick MH, Benhaim P. Rat extramedullary adipose tissue as a source of osteochondrogenic progenitor cells. Plast Reconstr Surg. 2002;109(3):1033–41.
15. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98(5):1076–84. This article provides a complete explanation of the mechanisms of activation and function of MSCs after their transplantation in the recipient tissue.
16. Roseti L, Serra M, Tigani D, Brognara I, Lorpiore A, Bassi A, et al. Cell manipulation in autologous chondrocyte implantation: from research to clean room. Chir Organi Mov. 2008;91(3):147–51.
17. Riis S, Zachar V, Boucher S, Vemuri MC, Pennisi CP, Fink T. Critical steps in the isolation and expansion of adipose-derived stem cells for translational therapy. Expert Rev Mol Med. 2015;17:e11.
18. Caplan A. Mesenchymal Stem Cells. J Orthopedic Res. 1991;9(5):641–50.
19. Caplan A, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med. 2001;7(6):259–64.
20. Caplan A. All MSCs are pericytes? Cell Stem Cell. 2008;3(3):229–30.
21. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Soon Park T, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3(3):301–13.
22. Da Silva Meirelles L, Caplan A, Beyer Nardi N. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008;26(9):2287–99.
23. Ledesma-Martinez E, Mendoza-Nunez VM, Santiago-Osorio E. Mesenchymal stem cells derived from dental pulp: a review. Stem cells Int. 2016;2016:4709572.
24. Kuang R, Zhang Z, Jin X et al. Nanofibrous spongy microspheres for the delivery of hypoxia-primed human dental pulp stem cells to regenerate vascularized dental pulp. Acta Biomater. 2016;33:225–234.
25. Dhillon K, Kaushik M, Sharma R. Regenerative endodontics—creating new horizons. J Biomed Mater Res B Appl Biomat. 2016;104(4):676–85.
26. Foldes A, Kadar K, Keremi B et al. Mesenchymal stem cells of dental origin-their potential for anti-inflammatory and regenerative actions in brain and gut damage. Curr Neuropharmacol. 2016 (in press).
27. Solemani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc. 2009;4(1):102–6.
28. Tonti GA, Mannello F. From bone marrow to therapeutic applications: different behavior and genetic/epigenetic stability during mesenchymal stem cells expansion in autologous and foetal bovine sera? Int J Dev Biol. 2008;52(8):1023–32.
29. Jang YO, Kim YJ, Baik SK, et al. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. Liver Int. 2014;34(1):33–41.
30. Vosough M, Moossavi S, Mardpour S, et al. Repeated intraportal injection of mesenchymal stem cells in combination with pioglitazone in patients with compensated cirrhosis: a clinical report of two cases. Arch Iran Med. 2016;19(2):131–6.
31. Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009;21(10):1199–205.
32. Mazzini L, Ferrero I. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Exp Neurol. 2010;223(1):229–37.
33. Jiang PC, Xiong WP, et al. A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injury. Exp Ther Med. 2013;6(1):140–6.
34. Oh SK, Choi KH, Yoo JY, Kim DY, Kim SJ, Jeon SR. A phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury. Neurosurgery. 2016;78(3):436–47.
35. García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA. A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005;48(7):1416–23.
36. Bianchi F, Maioli M, Leonardi E, Olivi E, Pasquinelli G, Valente S, et al. A new non enzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transpl. 2013;22:2063–77. This article highlights the basics of Lipogems technology, detailing how to use the device and the properties of the final product.
37. Von Heinburg D, Hemmrich K, Haydarlioglu S, et al. Comparison of viable cell yield from excised versus aspirated adipose tissue. Cells Tissues Organs. 2004;178:87.
38. Zhao Y, Betzler C, Popp F et al. Fair or foul: time for standard protocols for potential application of adipose-derived stem cells? Stem Cell Res Ther. 2014;4(7).
39. Strem BM, Hicok KC, Zhu M, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med. 2005;54:132.
40. Stolzing A, Jones E, McGonegle D, et al. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129(3):163–73.
41. Vangsness Jr CT, Sternberg H, Harris L. Umbilical cord tissue offers the greatest number of harvestable mesenchymal stem cells for research and clinical application: a literature review of different harvest sites. Arthroscopy. 2015;31(9):1836–43.
42. Ren H, Sang Y, Zhang F, Liu Z, Qi N, Chen Y. Comparative analysis of human mesenchymal stem cells from umbilical cord, dental pulp, and menstrual blood as sources for cell therapy. Stem Cells Int. 2016;2016:13. doi:10.1155/2016/3516574
43. Jeon YJ, Kim J, Cho JH, Chung HM, Chae JI. Comparative analysis of human mesenchymal stem cells derived from bone marrow, placenta, and adipose tissue as sources of cell therapy. J Cell Biochem. 2016;117(5):1112–25.
44. Coleman SR. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg. 2006;118(3S):108S–20.
45. Coleman SR. Structural fat grafting. Aesth Surg J. 1998;18(5):386–8.
46. Mestak O, Sukop A, Hsueh YS, et al. Centrifugation versus PureGraft for fat grafting to the breast after breast-conserving therapy. World J Surg Oncol. 2014;12:178.
47. Alexander RW. Autologous fat grafts as mesenchymal stromal stem cell source for use in prolotherapy: a simple technique to acquire lipoaspirants. J Prolotherapy. 2011;3(3):680–8.
48. Domenis R, Lazzaro L, Calabrese S, Mangoni D, Gallelli A, Bourkoula E, et al. Adipose tissue derived stem cells: in vitro and in vivo analysis of a standard and three commercially available cell-assisted lipotransfer techniques. Stem Cell Res Ther. 2015;6:2.
49. Zhu M, Cohen SR, Hicok KC, Shanahan RK, Strem BM, Yu JC, et al. Comparison of three different fat graft preparation methods: gravity separation, centrifugation, and simultaneous washing with filtration in a closed system. Plast Reconstr Surg. 2013;131(4):873–80.
50. Khojasteh A, Sadeghi N. Application of buccal fat pad-derived stem cells in combination with autogenous iliac bone graft in the treatment of maxillomandibular atrophy: a preliminary human study. Int J Oralmaxillofac Surg. 2016;45(7):864–871.
51. Tremolada C. Lipogems International Spa. US patent US9044547 B2, Jun 2015
52. Garcia-Contreras M, Messaggio F, Jimenez O, Mendez A. Differences in exosome content of human adipose tissue processed by non-enzymatic and enzymatic method. CellR4. 2014;3(1).
53. Oberbauer E, Steffenhagen C et al. Enzymatic and non-enzymatic isolation systems for adipose tissue-derived cells: current state of the art. Cell Regenerat. 2015; 4(7).
54. Carelli S, Messaggio F, Canazza A, et al. Characteristics and properties of mesenchymal stem cells derived from microfragmented adipose tissue. Cell Transplant. 2015;24(7):1233–52.
55. Tonnard P, Verpaele A, Peeters G, et al. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2012;132(4):1017–26.
56. Yu B, Zhang X. Li X exosomes derived from mesenchymal stem cells. Int J Mol Sci. 2014;15(3):4142–57.
57. Rani S, Ryan AE, Griffin MD, Ritter T. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther. 2015;23(5):812–23.
58. Sanderson JD, Simpson CB. Laryngeal complications after lipoinjection for vocal cord augmentation. Laryngoscope. 2009;119(8):1652–7.
59. Young VN, Wijewickrama RC, Pizzuto MA, Rosen CA. An unusual complication of vocal fold lipoinjection: case report and review of the literature. Arch Otolaryngol Head Neck Surg. 2012;138(4):418–20.
60. Saibene AM, Pipolo C, Lorusso R, Portaleone SM, Felisati G. Transnasal endoscopic microfractured fat injection in glottic insufficiency. B-ENT. 2015;11(3):229–34.
61. Cestaro G, De Rosa M, Massa S, Amato B, Gentile M. Intersphincteric anal lipofilling with micro-fragmented fat tissue for the treatment of faecal incontinence: preliminary results of three patients. Wideochir Inne Tech Maloinwazyjne. 2015;10(2):337–41.
62. Giori A, Tremolada C, Vailati R, Navone SE, Marfia G, Caplan AI. Recovery of function in anal incontinence after micro-fragmented fat graft (Lipogems®) injection: two years follow up of the first 5 cases. CellR4. 2015;3(2):e1544.
63. Testa A, Verdi A, Termini L. New frontiers of the treatment of perianal fistulas: the autologous transplantation of stem cells adult multipotent cells derived from human adipose tissue. 6th National Congress of the Italian Society of Colorectal Surgery Patients First: Quality of Care, Management, Multidisciplinary Approach, Treviso, Treviso, 2015. Tech Coloproctol. 2015;19:757–91.
64. Tremolada C, Beltrami G, Magri A, Bianchi F, Ventura C, Di Vito C, et al. Adipose mesenchymal stem cells and “regenerative adipose tissue graft” (Lipogems®)for musculoskeletal re generation. Eur J Muscoloskeletal Dis. 2014;3(2):57–67.
65. Striano RD, Chen H, Bilbool N, Azatullah K, Hilado J, Horan K. Non-responsive knee pain with osteoarthritis and concurrent meniscal disease treated with autologous micro-fragmented adipose tissue under continuous ultrasound guidance. CellR4. 2015; 3(5).
66. Franceschini M, Castellaneta C, Mineo G. Injection of autologous micro-fragmented adipose tissue for the treatment of post traumatic degenerative lesion of knee cartilage: a case report. CellR4. 2016;4(1).
67. Randelli P, Menon A et al. Lipogems product treatment increases the proliferation rate of human tendon stem cells withouth affecting their stemness and differentiation capability. Stem Cells Int. 2016;4373410. doi:10.1155/2016/4373410
68. Grossi P, Giarratana S, Cernei S, Grossi S, Doniselli FM. Low back pain treated with disc decompression and autologous micro-fragmented adipose tissue: a case report. CellR4. 2016;4(1).
69. Bianchi F, Olivi E, Baldassarre M, Giannone FA, Laggetta M, Valente S, et al. Lipogems®, a new modality off at tissue handling to enhance tissue repair in chronic hind limb ischemia. CellR4. 2014;2(6):1289.
70. Tremolada C, Palmieri G, Ricordi C. Adipose transplantation and stem cells. plastic surgery meets regenerative medicine. Cell Transplant. 2010;19(10):1217–23.
71. Raffaini M, Tremolada C. Micro fractured and purified adipose tissue graft (Lipogems®) can improve the orthognatic surgery outcomes both aesthetically and in postoperative healing. CellR4. 2014; 2(4).
72. Benzi R, Marfia G, Bosetti M, Beltrami G, Magri AS, Versari S, Tremolada C. Microfractured lipoaspirate may help oral bone and soft tissue re generation: a case report. CellR4. 2015; 3(3).
73. Bosetti M et al. Human lipoaspirate as autologous injectable active scaffold for one-step repair of cartilage defects. Cell Transpl. 2015;25(6):1043–1056.
74. Maioli M, Rinaldi S, Santaniello S, Castagna A, Pigliaru G, Delitala A, et al. Radioelectric asymmetric conveyed fields and human adipose-derived stem cells obtained with a nonenzymatic method and device: a novel approach to multipotency. Cell Transpl. 2014;23(12):1489–500.
75. Ventura C, Bianchi F, Cavallini C et al. The use of physical energy for tissue healing. Eur Heart J Suppl. 2015;17(A).
76. Del Papa N, Di Luca G, Sambataro D, Zaccara E, Maglione W, Gabrielli A, et al. Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with sistemi sclerosis. Cell Transplant. 2015;24(11):2297–305.
77. Del Papa N, Caviggioli F, Sambataro D, Zaccara E, Vinci V, Di Luca G, et al. Autologous fat grafting in the treatment of fibrotic perioral changes in patients with sistemi sclerosis. Cell Transplant. 2015;24(1):63–72.
78. Wang Y, Yuan M, Guo QY, Lu SB, Peng J. Mesenchymal stem cells for treating articular cartilage defects and osteoarthritis. Cell Transplant. 2015;24:1661–78.
79. Bourin P, Bunnel BA, Casteilla L, Dominici M, Katz AJ, March KI, et al. Stromal cells from the adipose tissue derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15(6):641–8.
80. Magalon J, Daumas A, Veran J, Magalon G, Rossi P, Granel B, et al. Autologous adipose tissue-derived cells: are we talking about adipose derived stem cells, stromal vascular fraction, or Coleman fat grafting? Cell Transplant. 2015;24:2667–8.
81. Zhao Y, Betzler C, Popp F, Bruns C. Fair or foul: time for standard protocols for potential application of adipose-derived stem cells? Stem Cell Res Ther. 2014; 4(7).